NCT04795882View on ClinicalTrials.gov

A New Study Evaluating the Activity of Modular CAR T for mYeloma

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 22, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2035

Conditions
Multiple Myeloma
Interventions
BIOLOGICAL

BCMA CAR T cells

Infusion with ATIMP: BCMA CAR T-cells

BIOLOGICAL

BCMA/CD19 CAR T cells

Infusion with ATIMP: BCMA/CD19 CAR T-cells

Trial Locations (1)

Unknown

University College London Hospital, London

All Listed Sponsors
lead

University College, London

OTHER